NTI to receive in-vitro results shortly – could its unique cannabis strain be a game changer?
ASX cannabis stocks are gaining momentum, stimulated by significant developments in the global regulatory environments in recent months. On the cusp of a potential rerate is $29M capped Neurotech International…